Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk
- 1 February 2008
- journal article
- Published by Elsevier BV in Journal of Thrombosis and Haemostasis
- Vol. 6 (2), 291-296
- https://doi.org/10.1111/j.1538-7836.2007.02839.x
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- The plasma kallikrein–kinin system and risk of cardiovascular disease in menJournal of Thrombosis and Haemostasis, 2007
- The intrinsic pathway of coagulation: a target for treating thromboembolic disease?Journal of Thrombosis and Haemostasis, 2007
- Evidence of a U‐shaped association between factor XII activity and overall survivalJournal of Thrombosis and Haemostasis, 2007
- The 46C→T polymorphism in the factor XII gene (F12) and the risk of venous thrombosisJournal of Thrombosis and Haemostasis, 2005
- Activated factor 12 (FXIIa) predicts recurrent coronary events after an acute myocardial infarctionAmerican Heart Journal, 2004
- Homozygosity for the CT polymorphism at nucleotide 46 in the 5' untranslated region of the factor XII gene protects from development of acute coronary syndromeBritish Journal of Haematology, 2001
- Measurement of activated factor XII in health and diseaseBlood Coagulation & Fibrinolysis, 1996
- Hageman factor and risk of myocardial infarction in middle-aged menAtherosclerosis, 1992
- Factor XII clotting activity and antigen levels in patients with thromboembolic diseaseBlood Coagulation & Fibrinolysis, 1992
- An analysis of 5'-noncoding sequences from 699 vertebrate messenger RNAsNucleic Acids Research, 1987